Your browser is out-of-date!

Update your browser to view this website correctly.

1Cookies

2Disclaimer

April was a positive month for both BB Biotech and the overall biotech sector in general. We are still seeing steady progress with the SARS-CoV-2 vaccine rollouts, and BB Biotech´s portfolio company Moderna provided a number of positive updates during April regarding vaccine production and delivery. In the US approximately 45% of the population has received one or more vaccine doses.

BB Biotech Update April

April was a positive month for both BB Biotech and the overall biotech sector in general. We are still seeing steady progress with the SARS-CoV-2 vaccine rollouts, and BB Biotech´s portfolio company Moderna provided a number of positive updates during April regarding vaccine production and delivery. In the US approximately 45% of the population has received one or more vaccine doses.
06.04.2021 - BB Biotech